|

|
Our main research subjects
1.
Development of novel bacterium-tracking antimicrobials
(Bacteriophage technology)
2. Pathogenicity and antibiotic resistance in Staphylococcal
species, especially in Staphylococcus aureus
(We now have more than 15,000 S. aureus collections
from about 25 countries)
3. Drug resistance in GN pathogens
4. Bacteriophage applications
5.
Infection control science
(Note: Three AMED programs and
one Moonshot programe are included)
|
|
|
1. Development of a
novel bacterium-tracking antimicrobial therapy against
antimicrobial-resistant bacteria
|
|

|
|
2a. Heterogeneity of bacterial populations and its impact on the
chronic persistent infection in human
|
|

|
|
2b.
Antibiotic resistance in staphyloccocal species, especitally in Staphylococcus aureus |
|

|
|
3.
Drug resistance in GN pathogenes |
|
We also research on antibiotic resistance of
opportunistic pathogens
including K. pneumoniae, P. aeruginosa
and A. baumannii, etc.
|
|
4.
Severe invasive infection by group A streptococci
|
|

|
|
5. Infection control science
|
|
In collaboration with clinical laboratory, our group
supports infection
control management in university teaching hospital by carrying out
basic study and laboratory surveillance.
|